The Critical Contribution of Pseudouridine to mRNA COVID-19 Vaccines
The current COVID-19 pandemic is a massive source of global disruption, having led so far to two hundred and fifty million COVID-19 cases and almost five million deaths worldwide. It was recognized in the beginning that only an effective vaccine could lead to a way out of the pandemic, and therefore...
Guardado en:
Autores principales: | Pedro Morais, Hironori Adachi, Yi-Tao Yu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fb6a4596b2f94b4cbe9d7cc377d7a8b6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview
por: Bruna Aparecida Souza Machado, et al.
Publicado: (2021) -
Humoral Response after Vaccination with Half-Dose of BNT162b2 in Subjects under 55 Years of Age
por: Krzysztof Lukaszuk, et al.
Publicado: (2021) -
Robust SARS-CoV-2 Antibody Responses in Asian COVID-Naïve Subjects 180 Days after Two Doses of BNT162b2 mRNA COVID-19 Vaccine
por: Chin-Shern Lau, et al.
Publicado: (2021) -
Transient increase in plasma HIV RNA after COVID-19 vaccination with mRNA-1272
por: Giorgio Bozzi, et al.
Publicado: (2021) -
RNA Vaccines against Infectious Diseases: Vital Progress with Room for Improvement
por: Hana M. Abdelzaher, et al.
Publicado: (2021)